Confronting the global burden of MASLD The Lancet Gastroenterology & Hepatology +... ++

Confronting the global burden of MASLD The Lancet Gastroenterology & Hepatology https://www.thelancet.com/journals/langas/issue/vol11no6/PIIS2468-1253(26)X2004-0 Robot-assisted versus conventional minimally invasive oesophagectomy for oesophageal squamous cell carcinoma (RAMIE): a multicentre, open-label, randomised, phase 3, non-inferiority trial Yang Yang, MDa,† ∙ Zhichao Liu, MDa,† ∙ Chunguang Li, MDa,† ∙ Bin Li, MDa ∙ Bentong Yu, MDc ∙ Jun Yi, MDd ∙ et al. https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00402-9/abstract?dgcid=raven_jbs_etoc_feature_langas Global burden of metabolic dysfunction-associated steatotic liver disease, 1990–2023, and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2023 GBD 2023 MASLD Collaborators* https://www.thelancet.com/journals/langas/article/PIIS2468-1253(26)00011-7/abstract?dgcid=raven_jbs_etoc_feature_langas